Exagen Inc reports results for the quarter ended in September - Earnings Summary

Exagen

11/11/2021 06:28

* Exagen Inc  XGN.OQ  reported a quarterly adjusted loss of 42
cents​​ per share for the quarter ended in September. The mean
expectation of six analysts for the quarter was for a loss of 46
cents per share.
* Revenue rose 13.7% to $12.25 million from a year ago; 
analysts expected $12.13 million. 
* Exagen Inc's reported EPS for the quarter was a loss of 42
cents​.
* The mean earnings estimate of analysts had fallen by
about 3.2% in the last three months.​ 
* In the last 30 days three analysts negatively revised earnings
estimates 
* Exagen Inc shares had fallen by 2.9% this quarter and held
steady so far this year.
* The company reported a quarterly loss of $7.18 million.
* Wall Street's median 12-month price target for Exagen Inc is
$24.00 
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
This summary was machine generated November 11 at 06:28 a.m.
 ​All figures in US dollars unless otherwise stated